YourEra logo

YourEra Review

Best for: $99 first-month entry pricing on compounded GLP-1s

YourEra is a LegitScript-certified telehealth platform offering compounded semaglutide and tirzepatide injections starting at $99 for the first month, with ongoing pricing set after the medical intake. Care runs entirely online, with doctor visits and prescriptions handled remotely. The site is upfront that these compounded medications are not the brand-name drugs Ozempic, Wegovy, Mounjaro, or Zepbound — a candid bit of transparency for the category.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7.1
★★★3.6
CompoundedSemaglutideTirzepatideLegitScript Verified
$99/mo
Same price at every dose
See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

YourEra is one of the most affordable GLP-1 options on the market.

Score: 7.1/10Best for: $99 first-month entry pricing on compounded GLP-1sFrom: $99/mo
YourEra logo
3.6 / 5
Our editorial rating
Visit YourEra

from $99/mo · no insurance needed

YourEra at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$99/mo
Pricing model
Flat — dose increases don't raise the monthly price
FDA status
No FDA warning letter on record

How we scored YourEra

Each dimension is scored algorithmically from YourEra’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

8.8/10

At $99/mo, YourEra runs about 41% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.6/10

YourEra offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.4/10

Online intake and platform experience; 4 platform features disclosed.

Trust & Safety15%

6.5/10

Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).

Accessibility10%

5.6/10

YourEra's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

5.4/10

YourEra provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this YourEra review

Last checked 2026-06-03
  • Confirmed current pricing across 2 dose/plan tiers
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications YourEra offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Compounded semaglutide (first month)Compounded
$99/mo
semaglutide
Compounded tirzepatide (first month)Compounded
$99/mo
tirzepatide

Ready to get started?

Plans and promotions change often — check YourEra's current pricing and active discounts before you decide.

See YourEra pricing →

What we like

  • $99 first-month entry pricing for compounded GLP-1 — among the cheapest in the market
  • LegitScript Certified
  • Clearly states it's 100% online doctor visits and prescriptions
  • Honest that the compounded medications aren't brand-name Ozempic, Wegovy, Mounjaro, or Zepbound

Watch-outs

  • Ongoing maintenance-dose price isn't published — ask before committing
  • Legal entity name and state of incorporation aren't disclosed
  • Pharmacy partners not named — only "state-licensed pharmacies"
  • Per-state availability not listed; verify your state ships before buying
  • Initial consultation fee not disclosed
  • Lab work and ongoing-care details aren't spelled out

YourEra: a rock-bottom entry price with a lot left unsaid

YourEra is a fully online telehealth service built around one very loud promise: get started on a compounded GLP-1 for $99 your first month. That headline rate covers compounded semaglutide or compounded tirzepatide, and it is among the lowest first-month figures anywhere in this category. The catch — and it's a real one — is that almost everything past that first month is left for you to find out after you've already started the intake. If you want a cheap, no-friction way to try a compounded GLP-1 and you're willing to ask pointed questions before you commit, YourEra is worth a look. If you want every cost and detail spelled out before you hand over a payment, this is not the most transparent option on the market.

How the $99 pricing actually works

The $99 figure is an entry rate for your first month, not a locked-in monthly price. YourEra does not publish what the ongoing maintenance dose costs once you move past that introductory month — and that's the single most important thing to understand here. A teaser price only matters if the steady-state price is reasonable, and right now you can't see it without going through the medical intake first. Before you let that first charge go through, ask plainly what the recurring monthly cost will be once the promo month ends.

There is one pricing detail in YourEra's favor: the site advertises a "Same Price at Every Dose" guarantee, meaning your cost shouldn't climb as your prescriber titrates you up to a higher dose. That's a genuinely patient-friendly structure — plenty of competitors charge more as your dose increases. YourEra also says it's FSA- and HSA-eligible across all plans, which can quietly shave the real cost if you have one of those accounts. For reference, the category median runs around $169 a month, so even a modestly priced maintenance tier here could land below average.

The medications and how they're dispensed

YourEra prescribes compounded semaglutide and compounded tirzepatide — the same active ingredients found in the brand-name GLP-1s, prepared by compounding pharmacies rather than the original manufacturers. To the company's credit, it states this plainly on its own site: these are not Ozempic, Wegovy, Mounjaro, or Zepbound. That kind of candor is unusual in a corner of the industry where a lot of marketing blurs the line, and it's the clearest signal that YourEra is being straight with you about what you're actually buying.

Everything runs remotely. YourEra describes its model as "100% online doctor visits and prescriptions," so there's no in-person clinic step — you complete an intake, a licensed prescriber reviews it, and the medication ships if you're cleared. The medications are made by what the company calls "state-licensed pharmacies that follow applicable state and federal regulations."

What's missing — and why it matters

Compounded GLP-1s are only as trustworthy as the pharmacy behind them, and this is where YourEra gets thin. It does not name its compounding pharmacy partners, list their accreditations, or disclose where they're located. "State-licensed pharmacies" is a regulatory baseline, not a quality credential. The gaps don't stop there:

  • The ongoing maintenance-dose price isn't published — only the first-month entry rate is verified.
  • The compounding pharmacy partners aren't named, so you can't independently check their accreditation or track record.
  • Per-state availability isn't listed; there's no published map of where YourEra actually ships, so confirm your state is covered before paying.
  • Any consultation fee, lab-work requirement, and ongoing-care details aren't spelled out up front.
  • The legal entity name and state of incorporation aren't disclosed, which makes the company harder to vet.

Trust and safety: what we can and can't confirm

On the positive side, YourEra displays a LegitScript certification, which is a meaningful third-party check — LegitScript verifies that an online pharmacy or telehealth operation meets legal and safety standards, and it's not trivial to earn. We also found no FDA warning letters on file for YourEra. So the foundational safety signal is reasonable. Our verification confidence is medium rather than high, though, because the LegitScript seal isn't paired with a visible approval number on the home page, the legal entity isn't named, and the pharmacy chain is anonymous. You're trusting a certification badge more than a fully documented operation.

Who should choose YourEra — and who should skip it

Choose YourEra if your top priority is the cheapest possible way to start a compounded GLP-1, you value the flat "same price at every dose" structure, and you're comfortable asking for the ongoing price and shipping details directly before you commit. The honesty about compounded-vs-brand and the LegitScript certification make it a defensible budget pick.

Skip it if you want full transparency up front. Patients who need to know their long-term monthly cost, the name and accreditation of the pharmacy filling their prescription, and exactly what's included before paying will find better-documented options elsewhere. There's nothing alarming on file here — but there's a lot simply not disclosed, and for a medication you may take for a year or more, that opacity is a fair reason to pass.

Bottom line

YourEra leads with one of the lowest first-month prices in the GLP-1 telehealth space and backs it with a flat-dose pricing guarantee, LegitScript certification, and refreshingly honest labeling of its compounded medications. The weakness is everything it leaves unstated: the real ongoing cost, the pharmacy partners, state coverage, and the company's own legal identity. Treat the $99 first month as a low-risk trial, not a long-term commitment, and pin down the recurring price and shipping eligibility before you continue. For a deeper look at how we weigh price transparency against safety signals, see our scoring methodology.

Ready to start with YourEra?

Starting at $99/month. See current pricing and start your free consultation.

Alternatives to YourEra

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.6/ 10
Verified partner

Novi

Best for: transparent all-in compounded GLP-1 pricing

★★★★4.3

Editorial score · methodology

$174/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Novi review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this YourEra review:

Sources & methodology — as of June 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with YourEra?

Starting at $99/month. See current pricing and start your free consultation.